ガーナの食品医薬品局は,世界保健機関に登録されるよう努力している
Mercy Owusu-Asante1, Delese Mimi Darko2, Seth Seaneke2
1School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; Food and Drugs Authority, Accra, Ghana.
Regulatory toxicology and pharmacology : RTP
|August 31, 2025
まとめ
食品医薬品局 (FDA) ガーナでは,良質な審査慣行 (GRevPs) を実施しているが,さらなる訓練と改善のためのタイムラインの遵守が必要である. この評価は,規制当局の基準の強化のためのベースラインを提供します.
科学分野:
- 規制科学
- 医薬品の品質保証
- 健康政策と管理
背景:
- ガーナ食品医薬品局 (FDA) は,医薬品と保健製品の重要な規制機関です.
- WHOのリストのような国際基準を目指す規制当局にとって,良い審査慣行 (GRevPs) の評価は極めて重要です.
- 現在の慣行を理解することで,規制の監督と効率性を強化する分野を特定できます.
研究 の 目的:
- 食品医薬品局 (FDA) ガーナにおける良好な審査慣行 (GRevPs) の現状を評価する.
- FDAガーナ内のGRevPの強化のための具体的な機会を特定する.
- WHOのリストに載っている権威の地位に向けた将来の改善のための基準を確立する.
主な方法:
- 構造化された多次元アンケートが ガーナのFDAの審査員に提出されました
- 30人の審査員のうち27人が研究に参加した.
- 収集されたデータは,GRevPの実施,採用,および認識された有効性に焦点を当てた.
主要な成果:
- 回答者の70%は,GevPが実施され,完全に採用されていることを示しました.
- GRevPの実施の鍵となる要因は,効率性,一貫性,エラー削減です.
- 回答者は,GRevPの枠組みの改善と追加の訓練の必要性を強調した.90%は一貫した文書化方法を確認したが,更新メカニズムの改善の余地があると指摘した.
結論:
- ガーナのFDAの査定官は,GRevPの重要性を認識しています.
- GRevPの目標タイムラインは一貫して遵守されていません.
- この研究は,FDAガーナがGRevPを改善し,WHOに登録された当局の地位に進むために不可欠なデータを提供します.
関連する概念動画
01:25Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
240
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
240
01:28International Nursing Organizations II
1.1K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.1K
01:19Pharmacovigilance
983
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
983
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:28Global Regulatory Systems
71
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
71